Showing results (461-470 of 700) with videos related to
Sort By:
Pageof 70
The New England Journal of Medicine|May 24, 2024
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 DiabetesVlado Perkovic, Katherine R Tuttle, Peter Rossing, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 23, 2026
Effect of semaglutide on COVID-19 and other infections: an analysis from the FLOW randomized clinical trialBrian Rayner, Kenneth W Mahaffey, Johannes F E Mann, et al.Diabetes & Vascular Disease Research|January 3, 2019
Cardiac ventricular sizes are reduced in patients with long-term, normoalbuminuric type 1 diabetes compared to the non-diabetic background populationHenrik Ø Hjortkjær, Tonny Jensen, Jannik Hilsted, et al.Plos One|October 15, 2008
Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized studySøren Søgaard Lund, Lise Tarnow, Anne Sofie Astrup, et al.American Journal of Preventive Cardiology|July 6, 2026
Impact of air pollution exposure on chronic kidney disease and type 2 diabetes: A FIDELITY analysisSadeer Al-Kindi, Zhuo Chen, Jean-Eudes Dazard, et al.European Journal of Clinical Investigation|April 24, 2012
Implementation of proteomic biomarkers: making it workHarald Mischak, John P A Ioannidis, Angel Argiles, et al.The Lancet. Diabetes & Endocrinology|March 6, 2020
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trialNete Tofte, Morten Lindhardt, Katarina Adamova, et al.Journal of Diabetes and Its Complications|February 25, 2023
Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria - A post-hoc analysis of the PRIORITY randomized clinical trialViktor Rotbain Curovic, Nete Tofte, Morten Lindhardt, et al.The Journal of Clinical Endocrinology and Metabolism|April 13, 2026
Combination Treatment for Management of Chronic Kidney Disease and Type 2 Diabetes: A Review and Practical GuidanceMai Mohsen, Tae Won Yi, Labib Faruque, et al.Diabetic Medicine : a Journal of the British Diabetic Association|January 12, 2021
Non-invasive assessment of temporal changes in myocardial microvascular function in persons with type 2 diabetes and healthy controlsIda K B Rasmussen, Philip Hasbak, Bernt J von Scholten, et al.Pageof 70